Author Archives: Dr Ken Harvey

About Dr Ken Harvey

Public Health Physician, Medical activitist

Independent Review of the Therapeutic Goods Advertising Framework: Recommendations

In 2018, the Hon Greg Hunt MP, Minister for Health, committed to a review of the impact of the new therapeutic goods advertising measures within two years from the commencement of the changes to the Therapeutic Goods Act 1989 to … Continue reading

Posted in Advertising, Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Complementary medicine weight loss products complaints submitted to the TGA in 2018-2019. Follow-up.

This research was conducted by a team of Monash University BSc students on a Work Integrated Learning (WIL) placement, supervised by Assoc Prof Ken Harvey. The team reviewed the following complaints submitted on: 6 July 2018, Pharmacare Laboratories FatBlaster FatMagnet products, … Continue reading

Posted in Advertising, Complementary medicine, Weight loss | Tagged , , , , , | Leave a comment

Towards independence from commercial interests in health

An important collection of resources from the British Medical Journal (BMJ) Growing evidence shows that extensive financial relationships between industry and healthcare decision makers distort scientific research, medical education and the practice of medicine. The biggest problem is that industry … Continue reading

Posted in Advertising, Education, Medicine policy, Pharmaceutical Promotion, Regulation | Tagged , , , , | Leave a comment

TGA stakeholder survey 2019

Perceptions of the regulation of complementary medicines: GPs & consumers This 2019 survey follows the first TGA (2018) survey of consumer perceptions about the regulation of complementary medicines. GPs were not surveyed in 2018. Pharmacists have yet to be surveyed. … Continue reading

Posted in Complementary medicine, Regulation | Tagged , , , , | Leave a comment

The TGA and COVID-19: Starting to use its compliance teeth!

Significant changes were made to the advertising framework of therapeutic goods during 2018-19. These included the TGA taking over the advertising complaint system, an updated, legally enforceable, advertising Code and stronger investigative and compliance powers. Yet the TGA initially appeared … Continue reading

Posted in Advertising | Tagged , | Leave a comment

COVID-19 Scams – ABC update on MMSAustralia

On 5 May 2020, ABC 7:30 (Grace Tobin) reported on the ‘Genesis II Church of Health and Healing’. The Australian branch, MMSAustralia.com.au currently promotes and sells Master Mineral Solution (MMS) – chlorine dioxide (a bleach) as a ‘sacrament of the Church’. … Continue reading

Posted in Advertising, Complementary medicine | Tagged | 1 Comment

COVID-19 Scams: Pulsed Electromagnetic Field Therapy (PEMF)

PEMF Therapy Australia promotes Pulsed Electromagnetic Field Therapy (PEMF) for the ‘Prevention and Healing Coronavirus Infections’ (and also other restricted representations such as diabetes). These devices do not appear to be listed on ARTG; they are therefore being illegally supplied … Continue reading

Posted in Advertising, Medical Devices | Tagged | 2 Comments

TGA clears Clive Palmer’s coronavirus ‘cure’ advertisement

It was reported that the Therapeutic Goods Administration (TGA) has dropped its investigation into newspaper advertisements taken out by the former federal politician Clive Palmer which said, ‘hydroxychloroquine was the best hope for those suffering COVID-19’. An advertisement is defined in the … Continue reading

Posted in Advertising | Tagged , , | 2 Comments

COVID-19 Scams: MMSAUSTRALIA.COM.AU – Chlorine dioxide

MMSAustralia.com.au currently describes itself as a ‘Ministry of the Genesis II Church of Health and Healing’. It promotes and sells Master Mineral Solution (MMS) – chlorine dioxide (a bleach) as a ‘sacrament of the Church’. For example, ‘Jim Humble Approved … Continue reading

Posted in Advertising, Complementary medicine | Tagged , , | 12 Comments

Pre-approval of advertisements for therapeutic goods ends on 30 June 2020.

Why remove pre-approval? Pre-approval of advertisements aimed to increase compliance with the Therapeutic Goods Advertising Code. However, it had substantial limitations. It only applied to advertisements for medicines, not medical devices, and only to those in ‘specified media’. The latter … Continue reading

Posted in Advertising | Tagged , , | Leave a comment